scPharmaceuticals (SCPH) News Today $2.50 -0.10 (-3.85%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Analysts Are Bullish on These Healthcare Stocks: scPharmaceuticals (SCPH), Sarepta Therapeutics (SRPT)April 23 at 9:37 PM | markets.businessinsider.comscPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest UpdatescPharmaceuticals Inc. (NASDAQ:SCPH - Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 4,820,000 shares, a decline of 15.0% from the March 15th total of 5,670,000 shares. Currently, 10.2% of the company's shares are sold short. Based on an average daily volume of 441,300 shares, the days-to-cover ratio is currently 10.9 days.April 23 at 5:09 AM | marketbeat.comCraig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)March 22, 2025 | markets.businessinsider.comscPharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results with Major FDA Approval for FUROSCIXMarch 22, 2025 | nasdaq.comscPharmaceuticals (NASDAQ:SCPH) Given New $12.00 Price Target at Maxim GroupMaxim Group reduced their price target on scPharmaceuticals from $20.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday.March 21, 2025 | marketbeat.comscPharmaceuticals Full Year 2024 Earnings: In Line With ExpectationsMarch 21, 2025 | finance.yahoo.comHC Wainwright Reiterates "Buy" Rating for scPharmaceuticals (NASDAQ:SCPH)HC Wainwright reiterated a "buy" rating and set a $18.00 target price on shares of scPharmaceuticals in a research note on Thursday.March 21, 2025 | marketbeat.comscPharmaceuticals price target lowered to $12 from $20 at MaximMarch 21, 2025 | markets.businessinsider.comscPharmaceuticals (NASDAQ:SCPH) Issues Earnings ResultsscPharmaceuticals (NASDAQ:SCPH - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.March 20, 2025 | marketbeat.comscPharmaceuticals (NASDAQ:SCPH) Announces Quarterly Earnings ResultsscPharmaceuticals (NASDAQ:SCPH - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.March 20, 2025 | marketbeat.comQ4 2024 scPharmaceuticals Inc Earnings CallMarch 20, 2025 | finance.yahoo.comscPharmaceuticals reports Q 4EPS (35c), consensus (39c)March 20, 2025 | markets.businessinsider.comscPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025March 19, 2025 | msn.comscPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides ...March 19, 2025 | gurufocus.comscPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 19, 2025 | globenewswire.comscPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025March 12, 2025 | globenewswire.comKing Luther Capital Management Corp Buys 632,120 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)King Luther Capital Management Corp raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 28.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,857,910 shareMarch 12, 2025 | marketbeat.comscPharmaceuticals announces FDA approval of Furoscix indication expansionMarch 7, 2025 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on scPharmaceuticals (SCPH)March 7, 2025 | markets.businessinsider.comFDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKDMarch 7, 2025 | finance.yahoo.comHC Wainwright Forecasts Lower Earnings for scPharmaceuticalsscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Investment analysts at HC Wainwright dropped their FY2024 earnings per share estimates for shares of scPharmaceuticals in a report issued on Monday, March 3rd. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings perMarch 7, 2025 | marketbeat.comscPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney DiseaseMarch 6, 2025 | globenewswire.comBrokers Set Expectations for SCPH FY2029 EarningsscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share estimates for scPharmaceuticals in a note issued to investors on Monday, March 3rd. HC Wainwright analyst D. Tsao expects that the company will earn $0.70 per share for theMarch 6, 2025 | marketbeat.comscPharmaceuticals (SCPH) Projected to Post Quarterly Earnings on WednesdayscPharmaceuticals (NASDAQ:SCPH) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.March 5, 2025 | marketbeat.comscPharmaceuticals (NASDAQ:SCPH) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $18.00 target price on shares of scPharmaceuticals in a report on Monday.March 3, 2025 | marketbeat.comscPharmaceuticals Announces Participation in Two Upcoming Investor ConferencesFebruary 26, 2025 | globenewswire.com85,184 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by Johnson Financial Group LLCJohnson Financial Group LLC purchased a new stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 85,184 shares of the company's stock, valued at approFebruary 26, 2025 | marketbeat.comShareholders in scPharmaceuticals (NASDAQ:SCPH) have lost 68%, as stock drops 12% this past weekFebruary 24, 2025 | uk.finance.yahoo.comRice Hall James & Associates LLC Has $3.50 Million Stock Position in scPharmaceuticals Inc. (NASDAQ:SCPH)Rice Hall James & Associates LLC lifted its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 59.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 989,635 shares of the company's stock after purchasing anFebruary 19, 2025 | marketbeat.comscPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | markets.businessinsider.comscPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 5, 2025 | globenewswire.comscPharmaceuticals Inc.: scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial ResultsJanuary 10, 2025 | finanznachrichten.descPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial ResultsJanuary 10, 2025 | globenewswire.comCentessa Pharmaceuticals (CNTA) Initiated with a Buy at TD CowenJanuary 8, 2025 | markets.businessinsider.comscPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To ProfitDecember 31, 2024 | finance.yahoo.comTD Cowen Sticks to Its Buy Rating for scPharmaceuticals (SCPH)December 12, 2024 | markets.businessinsider.comCraig-Hallum Issues a Buy Rating on scPharmaceuticals (SCPH)December 11, 2024 | markets.businessinsider.comScPharmaceuticals Stock Falls After Noting Possible FDA Submission DelayDecember 11, 2024 | marketwatch.comSuvretta Capital Management LLC Purchases New Position in scPharmaceuticals Inc. (NASDAQ:SCPH)Suvretta Capital Management LLC acquired a new position in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,049,009 shares of the company'sNovember 29, 2024 | marketbeat.comscPharmaceuticals Inc. (NASDAQ:SCPH) Shares Bought by Rubric Capital Management LPRubric Capital Management LP lifted its position in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 35.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,775,000 shares of the company's stock after buying an addNovember 27, 2024 | marketbeat.comHC Wainwright Has Bearish Estimate for SCPH FY2024 EarningsscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Investment analysts at HC Wainwright reduced their FY2024 earnings per share (EPS) estimates for shares of scPharmaceuticals in a note issued to investors on Thursday, November 14th. HC Wainwright analyst D. Tsao now expects that the company wiNovember 18, 2024 | marketbeat.comEarnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their ForecastsNovember 16, 2024 | finance.yahoo.comscPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | insidermonkey.comPositive Outlook for scPharmaceuticals: Strategic Growth and Regulatory Milestones Drive Buy RatingNovember 16, 2024 | markets.businessinsider.comscPharmaceuticals price target lowered to $12 from $16 at Craig-HallumNovember 15, 2024 | markets.businessinsider.comPositive Buy Rating for scPharmaceuticals Driven by Strong Furoscix Launch and Strategic Growth InitiativesNovember 14, 2024 | markets.businessinsider.comscPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comscPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | globenewswire.comscPharmaceuticals's Earnings OutlookNovember 12, 2024 | benzinga.com Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address SCPH Media Mentions By Week SCPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPH News Sentiment▼0.940.72▲Average Medical News Sentiment SCPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPH Articles This Week▼32▲SCPH Articles Average Week Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Prothena News Kura Oncology News Sionna Therapeutics News Cogent Biosciences News Akebia Therapeutics News Tyra Biosciences News GH Research News Cullinan Therapeutics News Relay Therapeutics News Stoke Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPH) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SCPH Stock Free SCPH Stock Alerts